Cetreva OÜ
Cetreva OÜ is a OÜ based in , registry code 14875280, status: active. Main activity: Manufacture of medicines and other pharmaceutical preparations. According to EMTA, turnover for Q4 2025 was €0 with employees.
Q4 2025 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Revenue · 2023 0 €above 5% of companiesindustry median 3 851 € · companies in the industry: 24
Taxes and turnover
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q4 2025 | — | — | — | — |
| Q3 2025 | — | — | — | — |
| Q2 2025 | — | — | — | — |
| Q1 2025 | — | — | — | — |
| Q4 2024 | — | — | — | — |
| Q3 2024 | — | — | — | — |
| Q2 2024 | — | — | — | — |
| Q1 2024 | — | — | — | — |
| Q4 2023 | — | — | — | — |
| Q3 2023 | — | — | — | — |
| Q2 2023 | — | — | — | — |
| Q1 2023 | — | — | — | — |
| Q4 2022 | — | — | — | — |
| Q3 2022 | — | — | — | — |
| Q2 2022 | — | — | — | — |
| Q1 2022 | — | — | — | — |
Financials by year
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Manufacture of basic pharmaceutical products and pharmaceutical preparations (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2024 | — | -1 000 | 0 | 587 | -1 000 | 0 |
| 2023 | 0 | -1 000 | 0 | 537 | -1 000 | 0 |
| 2022 | — | -1 000 | 0 | 537 | -1 000 | 0 |
| 2021 | — | -1 000 | 0 | 389 | -1 000 | 0 |
| 2020 | 0 | -1 063 | 0 | — | -1 063 | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2024
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 30 Jun 2025 | Company’s own | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 30 Jun 2024 | Company’s own | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 20 Jun 2023 | Company’s own | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 27 Jul 2022 | Company’s own | e-Äriregister |
| 2020 | 27 Dec 2019 – 31 Dec 2020 | 31 Mar 2021 | Company’s own | e-Äriregister |
Board
- Haytham Elsayed Ahmed MetwalyBoard member · since 27 Dec 2019
- Mamdouh Sayed Hassan AhmedBoard member · since 27 Dec 2019
- Abdelfattah Amin Mohamed MetwalyBoard member · since 18 Jan 2021
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Mamdouh sayed hassan AhmedNatural person · 1 250 €
- Haytham Elsayed Ahmed MetwalyNatural person · 1 250 €
Beneficial owners
- Abdelfattah Amin Mohamed MetwalyDirect ownership · EGY · since 8 Dec 2020
- Haytham Elsayed Ahmed MetwalyDirect ownership · EGY · since 27 Dec 2019
- Mamdouh Sayed Hassan AhmedDirect ownership · EGY · since 27 Dec 2019
Founders and other persons
- Haytham Elsayed Ahmed MetwalyFounder · 1 250 € · 25 Dec 2019
- Mamdouh sayed hassan AhmedFounder · 1 250 € · 25 Dec 2019
Related companies
Activities (EMTAK)
- 21201Manufacture of medicines and other pharmaceutical preparations Main
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 50135470 / M6 10 Jul 2025 |
Procedural ruling | 24 Jul 2025 | In force 10 Jul 2025 |
|
| Ä 50135470 / 8 11 Nov 2024 |
Entry made by the register on its own initiative | In force 11 Nov 2024 |
||
| Ä 50135470 / M5 15 Oct 2024 |
Procedural ruling | 29 Oct 2024 | In force 15 Oct 2024 |
|
| Ä 50135470 / 7 15 Mar 2024 |
Amendment entry | In force 15 Mar 2024 |
||
| Ä 50135470 / 6 1 Sep 2023 |
Amendment entry | In force 1 Sep 2023 |
||
| Ä 50135470 / 5 30 Mar 2023 |
Amendment entry | In force 30 Mar 2023 |
||
| Ä 50135470 / M4 27 Mar 2023 |
Ruling to eliminate deficiencies | 17 Apr 2023 | Deficiencies eliminated 30 Mar 2023 |
|
| Ä 50135470 / M3 28 Jun 2022 |
Ruling to eliminate deficiencies in the annual report | 28 Jul 2022 | Deficiencies eliminated 27 Jul 2022 |
|
| Ä 50135470 / 4 18 Jan 2021 |
Amendment entry | In force 18 Jan 2021 |
||
| Ä 50135470 / 3 18 May 2020 |
Amendment entry | In force 18 May 2020 |
||
| Ä 50135470 / 2 17 Apr 2020 |
Entry refused: deficiencies not eliminated | In force 2 May 2020 |
||
| Ä 50135470 / M2 20 Feb 2020 |
Ruling to eliminate deficiencies | 1 Mar 2020 | In force 20 Feb 2020 |
|
| Ä 50135470 27 Dec 2019 |
First entry | In force 27 Dec 2019 |
||
| Ä 50135470 / M1 17 Dec 2019 |
Ruling to eliminate deficiencies | 16 Jan 2020 | Deficiencies eliminated 27 Dec 2019 |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data